Pay in 4 interest-free payments of $32.50 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151
Pomalidomide
by injection into a muscle
ONO-AE3-208 is a potent n EP4 antagonist (Ki = 1
1-5H3/t20-/m1/s1
CNX-2006 - CAS# 1375465-09-0 smopressin From ApoA1 upregulation to BETCNX 2006 is a potent, mutant selective EGFR inhibitor with excellent in vitro activity in cells with activating EGFR mutations, as well as in cells harbouring the T790M mutation. CNX 2006 is the prototype for CO 1686, which is currently in a Phase I clinical trial for the treatment of EGFR mutant lung cancer. Product information CAS Number: 1375465 09 0 Molecular Weight: 545. 53 Formula: C26H27F4N7O2 Synonym: CNX2006 CNX 2006 Chemical Name: N [3 ({2
US$ 162.50
US$ 375.00
US$ 275.00
US$ 222.50
US$ 130.00